Alpinin A exhibits significant anti-inflammatory and neuroprotective properties, making it a compound of interest in the development of treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. It modulates key signaling pathways involved in oxidative stress and neuronal apoptosis, helping to preserve cognitive function in preclinical models. Additionally, Alpinin A has shown potential in suppressing pro-inflammatory cytokines, suggesting utility in managing chronic inflammatory conditions. Its ability to cross the blood-brain barrier enhances its effectiveness in central nervous system-targeted therapies. Research is ongoing to explore its application in functional foods and natural health products aimed at cognitive support and neuroprotection.